The HF-associated augmentation of classically-activated macrophages was not significantly alleviated by therapeutic Lum administration when assessing all CD80+ macrophages in the lung (Figure 6A), however, therapeutic CFTR correction significantly attenuated the HF-associated increase of non-alveolar CD80+ macrophages (Figure 6B). The gene discussed is CFTR; the disease is hydrops fetalis.